- Home
- CBZ vs JANX Comparison
CBZ vs JANX Comparison
Compare CBZ & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBZ
- JANX
- Stock Information
- Founded
- CBZ 1987
- JANX 2017
- Country
- CBZ United States
- JANX United States
- Employees
- CBZ N/A
- JANX N/A
- Industry
- CBZ Business Services
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- CBZ Consumer Discretionary
- JANX Health Care
- Exchange
- CBZ Nasdaq
- JANX Nasdaq
- Market Cap
- CBZ 3.9B
- JANX 3.6B
- IPO Year
- CBZ N/A
- JANX 2021
- Fundamental
- Price
- CBZ $80.65
- JANX $56.83
- Analyst Decision
- CBZ Strong Buy
- JANX Strong Buy
- Analyst Count
- CBZ 1
- JANX 11
- Target Price
- CBZ $86.00
- JANX $83.09
- AVG Volume (30 Days)
- CBZ 347.4K
- JANX 1.7M
- Earning Date
- CBZ 02-13-2025
- JANX 11-06-2024
- Dividend Yield
- CBZ N/A
- JANX N/A
- EPS Growth
- CBZ N/A
- JANX N/A
- EPS
- CBZ 2.37
- JANX N/A
- Revenue
- CBZ $1,680,740,000.00
- JANX $13,049,000.00
- Revenue This Year
- CBZ $11.68
- JANX $40.27
- Revenue Next Year
- CBZ $25.55
- JANX N/A
- P/E Ratio
- CBZ $34.35
- JANX N/A
- Revenue Growth
- CBZ 7.83
- JANX 54.12
- 52 Week Low
- CBZ $60.59
- JANX $7.79
- 52 Week High
- CBZ $86.36
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- CBZ 55.37
- JANX 50.66
- Support Level
- CBZ $77.14
- JANX $54.20
- Resistance Level
- CBZ $82.56
- JANX $66.34
- Average True Range (ATR)
- CBZ 2.12
- JANX 5.47
- MACD
- CBZ -0.39
- JANX -0.57
- Stochastic Oscillator
- CBZ 50.15
- JANX 15.02
About CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional business services. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Agribusiness, Agribusiness, SAAS, Construction, Health Care, Oil and Gas, Real Estate, Retail, Financial Institutions, and Government among others. It derives the majority of its revenues from the Financial Services segment and geographically from the United States.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.